RE-186-MM-1
RHENIUM (186Re) SULPHIDE
| Name | RHENIUM (186Re) SULPHIDE CIS bio International |
| Pharmaceutical form | Colloidal suspension for local injection |
| Nuclide | Rhenium 186 |
| Half life | 3.77 days |
| Availability | Tuesday |
| Ordering deadline | Friday before 11 a.m. |
| Radioactive concentration | 148 to 370 MBq/mL |
| Calibration | Saturday 12 a.m. |
| Available quantities | From 37 to 3700 MBq |
| Expiry | 10 days from the manufacturing date |
| Specific activity | 2000 to 7400 MBq/mg |
| Radiochemical purity | ≥ 95 % |
| Radionuclidic purity | 186Re ≥ 99 %; 184Re + 188Re ≤ 1% |
| pH and composition | 3.5 - 5.5, colloidal suspension stabilised with gelatine |
| Storage | Not above 25°C |
| Indication | • Treatment of rheumatoid mono or oligo arthritis involving medium-sized joints (shoulders, elbows, wrists, ankles, hips) and particularly rheumatoid polyarthritis • Treatment of haemophilic or chronic arthropathy associated with articular chondrocalcinosis |
Support Solution
Practical training with experts upon request to rheumatologists / Orhtopaedists/Nuclear Doctors
